Pharmaceuticals

Main33.JPG

RAS-Targeting Drugs for Precision Oncology Market Size, Share & Trends Analysis Distribution by Drug Type (Small Molecule Inhibitors, Biologics, RNA-Based Therapies, Combination Therapies), Target Mutation (KRAS G12C, KRAS G12D, KRAS G12V, G12R, G12S, G12A, HRAS and NRAS, Pan-RAS), Indication (Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC), Other Cancers (e.g., HNSCC, melanoma, hematologic)), Route of Administration (Oral, Intravenous, Other Routes) and Segment Forecasts, 2025-2034

Global RAS-Targeting Drugs for Precision Oncology Market Size is predicted to grow with a 11.9% CAGR during the forecast period for 2025-2034. The RAS-targeting medicines in precision oncology is a fast-developing area dedicated to treatments t...

View Sample PDF

Mobile_Healthcare_Clinic_Market.JPG

Mobile Healthcare Clinic Market Size, Share & Trends Analysis Report By Service Type (Maternal Health, Emergency Care, Geriatric Care, Dental Care, OPD, Others), By Vehicle Type, By Design Layout, By Region, And By Segment Forecasts, 2025-2034

Mobile Healthcare Clinic Market Size is valued at USD 2.11 Bn in 2024 and is predicted to reach USD 5.82 Bn by the year 2034 at a 10.8% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Increas...

View Sample PDF

Slide2-min_(6)40.JPG

Particle Therapy Market Size, Share & Trends Analysis Report By Type (Proton Type, Heavy Ion Therapy), By Product & Service (Cyclotrons, Synchrotrons, Synchrocyclotrons), By System, By Cancer Type, By Application, By Region, And By Segment Forecasts, 2025-2034

Particle Therapy Market Size is valued at USD 753.10 Mn in 2024 and is predicted to reach USD 1796.73 Mn by the year 2034 at a 9.3% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Particle ther...

View Sample PDF

Digital_Pharmaceutical_Supply_Chain_Management_Market.JPG

Digital Pharmaceutical Supply Chain Management Market Size, Share & Trends Analysis Report by Product (Software, Hardware), By Mode Of Delivery (Cloud-based, Web-based, and On -premises), By Software Modules (Software Modules Planning & Analytics, Procurement, Manufacturing, Logistics, and Inventory management) By Region, And By Segment Forecasts, 2025-2034

Digital Pharmaceutical Supply Chain Management Market Size is valued at USD 1163.34 million in 2024 and is predicted to reach USD 2534.55 million by the year 2034 at an 8.2% CAGR during the forecast period for 2025-2034. Key Insights: The incre...

View Sample PDF

Main28.JPG

Quinapril Hydrochloride Market Size, Share & Trends Analysis Report By Formulation Type (Tablet, Injection), By Application (Hypertension, Heart Failure, Cardiovascular Diseases, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)), by Region, And by Segment Forecasts, 2025-2034.

Global Quinapril Hydrochloride Market Size is valued at USD 1.3 Bn in 2024 and is predicted to reach USD 2.2 Bn by the year 2034 at a 5.9% CAGR during the forecast period for 2025-2034. The prescription drug quinapril hydrochloride belongs to the ph...

View Sample PDF

Chronic_Rhinosinusitis_with_Nasal_Polyps_Market.JPG

Chronic Rhinosinusitis with Nasal Polyps Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatments (Corticosteroids, Antibiotics, Biologic Drugs, Antihistamines, Leukotriene Modifiers), Surgical Interventions, Others), By Route of Administration (Oral, Nasal, Injectable), By Distribution (Direct Sales, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialized Clinics and ENT Practices, Ambulatory Surgical Centers)), by Region, And by Segment Forecasts, 2025-2034.

Chronic Rhinosinusitis with Nasal Polyps Market Size is valued at USD 1.8 Bn in 2024 and is predicted to reach USD 3.4 Bn by the year 2034 at a 6.6% CAGR during the forecast period for 2025-2034. Chronic rhinosinusitis with nasal polyps (CRSwNP) i...

View Sample PDF

Slide2-min_(5)9.JPG

Radioligand Therapy Market Size, Share & Trends Analysis Report By Target(Prostate-Specific Membrane Antigen, Cancerous bone lesions, Somatostatin receptor type 2 (SSTR2)), By Indications, By Products, By Emission By Region, And By Segment Forecasts, 2025-2034

The Radioligand Therapy Market Size is valued at USD 2.31 Billion in 2024 and is predicted to reach USD 8.33 Billion by the year 2031 at a 12.1% CAGR during the forecast period for 2025-2034.   Radioligand therapy (RLT) is a cancer treatm...

View Sample PDF

Orodispersible_Tablets_Market.JPG

Orodispersible Tablets Market Size, Share & Trends Analysis Report by Drug Class (Analgesics, Antiemetics, Antipsychotics, Anti-inflammatory Drugs, Sedatives/Hypnotics, Antihypertensives, Others), By Disease Indication (Central Nervous System Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Respiratory Disorders, Allergy and Asthma, Others), By Distribution Channel, By Age Group, By End User, By Technology , Region And Segment Forecasts, 2023-2031

Orodispersible Tablets Market Size is valued at 10.71 billion in 2024 and is predicted to reach 29.47 billion by the year 2034 at a 10.8% CAGR during the forecast period for 2025-2034. The orodispersible tablets market, known as orally disintegratin...

View Sample PDF

Live_Cell_Encapsulation_Market.JPG

Live Cell Encapsulation Market Size, Share & Trends Analysis Report, By Therapeutic Area (Eye Disorders, Metabolic Disorders, Neurological Disorders, and Oncological Disorders), By Target Disease Indication, By Type of Encapsulation Material, By Region, Forecasts, 2025-2034

Live Cell Encapsulation Market Size Was valued at USD 174.2 Mn in 2024 and is predicted to reach USD 305.5 Mn by 2034 at a 5.9% CAGR during the forecast period for 2025-2034. The technique of encasing living cells in a protective matrix or structu...

View Sample PDF

Oral_Solid_Dosage_Contract_Manufacturing_Market.JPG

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules, Powders, Granules), Mechanism (Immediate-Release, Delayed-Release, And Controlled-Release), And End-User (Large-Size Companies, Medium- & Small-Size Companies), Region And Segment Forecasts, 2025-2034

Global Oral Solid Dosage Contract Manufacturing Market Size is valued at USD 35.6 Bn in 2024 and is predicted to reach USD 63.5 Bn by the year 2034 at a 6.0% CAGR during the forecast period for 2025-2034. Oral Solid Dosage Contract Manufacturing are...

View Sample PDF

Categories